Published in Clin Exp Immunol on September 01, 2006
CC chemokine receptor 4 modulates Toll-like receptor 9-mediated innate immunity and signaling. Eur J Immunol (2008) 0.92
DNA attenuates enterocyte Toll-like receptor 4-mediated intestinal mucosal injury after remote trauma. Am J Physiol Gastrointest Liver Physiol (2011) 0.86
A nonsynonymous polymorphism of IRAK4 associated with increased prevalence of gram-positive infection and decreased response to toll-like receptor ligands. J Innate Immun (2011) 0.84
Advances in the understanding of mitochondrial DNA as a pathogenic factor in inflammatory diseases. F1000Res (2017) 0.75
Prediction of sepsis in trauma patients. Burns Trauma (2014) 0.75
The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma (1974) 47.36
A Toll-like receptor recognizes bacterial DNA. Nature (2000) 26.34
Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature (2002) 11.05
Innate immune recognition of viral infection. Nat Immunol (2006) 9.59
TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol (2004) 8.06
Epidemiology of trauma deaths: a reassessment. J Trauma (1995) 6.60
Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med (1997) 5.19
Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci U S A (2001) 5.02
The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells. Blood (2003) 2.57
The immunobiology of the TLR9 subfamily. Trends Immunol (2004) 2.11
CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study. J Clin Immunol (2004) 1.98
Plasma DNA as a prognostic marker in trauma patients. Clin Chem (2000) 1.90
Treatment results of patients with multiple trauma: an analysis of 3406 cases treated between 1972 and 1991 at a German Level I Trauma Center. J Trauma (1995) 1.42
Expression of toll-like receptors on B lymphocytes. Cell Immunol (2005) 1.33
HLA-DR expression and soluble HLA-DR levels in septic patients after trauma. Ann Surg (1999) 1.31
DNA activates human immune cells through a CpG sequence-dependent manner. Immunology (1999) 1.23
Toll-like receptor-mediated tumor necrosis factor and interleukin-10 production differ during systemic inflammation. Am J Respir Crit Care Med (2003) 1.11
Toll-like receptor 9 can be expressed at the cell surface of distinct populations of tonsils and human peripheral blood mononuclear cells. Infect Immun (2004) 1.03
Effect of granulocyte-macrophage colony-stimulating factor on the immune response of circulating monocytes after severe trauma. Crit Care Med (2003) 1.00
Regulation of whole blood tumor necrosis factor production upon endotoxin stimulation after severe blunt trauma. J Trauma (1997) 0.98
Human monocytes infected with Yersinia pestis express cell surface TLR9 and differentiate into dendritic cells. J Immunol (2004) 0.97
Toll receptor families: structure and function. Semin Immunol (2004) 0.94
An outcome predictive score for sepsis and death following injury. Injury (1988) 0.92
Immunology: DNA drives autoimmunity. Nature (2002) 0.85
Reduced B cell HLA-DR expression and natural killer cell counts in patients prone to sepsis after injury. Eur J Surg (1999) 0.82
Early intubation in severely injured patients. Eur J Emerg Med (1994) 0.81
Human leukocyte antigen-DR expression in peripheral blood mononuclear cells from healthy donors influenced by the sera of injured patients prone to severe sepsis. Intensive Care Med (2003) 0.78
Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. Science (1998) 5.05
Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci U S A (1996) 4.69
An activating immunoreceptor complex formed by NKG2D and DAP10. Science (1999) 4.56
Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc Natl Acad Sci U S A (1999) 4.40
Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences. Am J Hum Genet (1997) 3.08
Protein kinase C phosphorylates the inhibitory guanine-nucleotide-binding regulatory component and apparently suppresses its function in hormonal inhibition of adenylate cyclase. Eur J Biochem (1985) 3.04
Echinococcus multilocularis in an imported captive European beaver (Castor fiber) in Great Britain. Vet Rec (2011) 2.86
Statement on the nomenclature of human C4 allotypes. Immunobiology (1983) 2.66
Primary gastric B-cell lymphoma: results of a prospective multicenter study. The German-Austrian Gastrointestinal Lymphoma Study Group. Gastroenterology (2000) 2.65
Functional significance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br J Clin Pharmacol (1999) 2.57
The risks of blood transfusion: the relative influence of acquired immunodeficiency syndrome and non-A, non-B hepatitis. Am J Med (1992) 2.12
Higher blood flow and circulating NO products offset high-altitude hypoxia among Tibetans. Proc Natl Acad Sci U S A (2007) 2.07
Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum). Clin Pharmacol Ther (1999) 1.96
Autoradiographic study of mannan incorporation into the growing cell walls of Saccharomyces cerevisiae. J Bacteriol (1974) 1.94
A new rapid slide test for infectious mononucleosis. JAMA (1965) 1.82
Inhibition by interferon of SV40 tumor antigen formation in cells injected with SV40 cRNA transcribed in vitro. FEBS Lett (1974) 1.82
Intravenous levetiracetam in the treatment of benzodiazepine refractory status epilepticus. J Neurol Neurosurg Psychiatry (2007) 1.80
Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood (1996) 1.78
Worldwide ethnic distribution of the G protein beta3 subunit 825T allele and its association with obesity in Caucasian, Chinese, and Black African individuals. J Am Soc Nephrol (1999) 1.76
Soluble CD4, CD8, and HLA molecules in commercial immunoglobulin preparations. Lancet (1993) 1.76
Frequency of cytochrome P450 CYP2C9 variants in a Turkish population and functional relevance for phenytoin. Br J Clin Pharmacol (1999) 1.76
A follow-up study of morbidity and mortality associated with hepatitis C virus infection and its interaction with human T lymphotropic virus type I in Miyazaki, Japan. J Infect Dis (2000) 1.71
Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. Br J Cancer (2008) 1.70
Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation. Lancet (1993) 1.68
The surrogate light chain in B-cell development. Immunol Today (1993) 1.64
Autoimmune human T lymphocytes specific for acetylcholine receptor. Nature (1984) 1.63
Dense growth of aerobic bacteria in a bench-scale fermentor. Biotechnol Bioeng (1976) 1.62
Anti-CD16/CD30 bispecific antibody treatment for Hodgkin's disease: role of infusion schedule and costimulation with cytokines. Clin Cancer Res (2001) 1.62
Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo. Cancer Res (1997) 1.56
Analysis of the SlyA-controlled expression, subcellular localization and pore-forming activity of a 34 kDa haemolysin (ClyA) from Escherichia coli K-12. Mol Microbiol (1999) 1.55
Endoscopic evaluation of exercise-induced pulmonary hemorrhage and chronic obstructive pulmonary disease in association with poor performance in racing Standardbreds. J Am Vet Med Assoc (1990) 1.51
Secretion of cell-wall glycoproteins by yeast protoplasts. Effect of 2-deoxy-D-glucose and cycloheximide. Biochem J (1970) 1.48
Lack of DNA synthesis among CD34+ cells in cord blood and in cytokine-mobilized blood. Br J Haematol (1996) 1.48
Detection of chromium allergy by cellular in vitro methods. Clin Exp Allergy (2008) 1.47
Antibody profile of early HTLV-I infection. Lancet (1990) 1.46
The extent of traumatic damage determines a graded depression of the endotoxin responsiveness of peripheral blood mononuclear cells from patients with blunt injuries. Crit Care Med (1999) 1.46
SlyA, a regulatory protein from Salmonella typhimurium, induces a haemolytic and pore-forming protein in Escherichia coli. Mol Gen Genet (1995) 1.45
Arterial hypoxemia following the administration of sublingual nitroglycerin. Am Heart J (1978) 1.44
Effect of surgical repair on the neurologic function in infants with lipomeningocele. Pediatr Neurosurg (1993) 1.40
Monitoring of soluble HLA class I size variants after liver transplantation. Hum Immunol (1999) 1.40
Modulation of adenylate cyclase of human platelets by phorbol ester. Impairment of the hormone-sensitive inhibitory pathway. Eur J Biochem (1985) 1.39
Demonstration of cGMP-dependent protein kinase and cGMP-dependent phosphorylation in cell-free extracts of platelets. Eur J Biochem (1986) 1.31
Extracellular beta-glucanases of the yeast, Saccharomyces cerevisiae. Biochim Biophys Acta (1973) 1.31
HLA-DR expression and soluble HLA-DR levels in septic patients after trauma. Ann Surg (1999) 1.31
Protection of rhesus monkeys from fatal Lassa fever by vaccination with a recombinant vaccinia virus containing the Lassa virus glycoprotein gene. Proc Natl Acad Sci U S A (1989) 1.25
The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia. Leukemia (2010) 1.25
Metabolism of 2-deoxy-D glucose by Baker's yeast. IV. Incorporation of 2-deoxy-D-glucose into cell wall mannan. Biochim Biophys Acta (1972) 1.24
High mobility, low voltage operating C(60) based n-type organic field effect transistors. Synth Met (2011) 1.21
Xylan-degrading activity in yeasts: growth on xylose, xylan and hemicelluloses. Folia Microbiol (Praha) (1978) 1.20
Crystal structure of the MHC class I homolog MIC-A, a gammadelta T cell ligand. Immunity (1999) 1.19
HLA-D typing in multiple sclerosis: Israelis tested with European homozygous typing cells. Tissue Antigens (1982) 1.19
Mechanism of 2-deoxy-D-glucose inhibition of cell-wall polysaccharide and glycoprotein biosyntheses in Saccharomyces cerevisiae. Eur J Biochem (1975) 1.18
Commissioning of a micro multi-leaf collimator and planning system for stereotactic radiosurgery. Radiother Oncol (1999) 1.18
Herpesvirus-like DNA sequences detected in endemic, classic, iatrogenic and epidemic Kaposi's sarcoma (KS) biopsies. Int J Cancer (1996) 1.18
T cells from patients with Hodgkin's disease have a defective T-cell receptor zeta chain expression that is reversible by T-cell stimulation with CD3 and CD28. Blood (1996) 1.17
Association of soluble HLA-G plasma levels with HLA-G alleles. Tissue Antigens (2001) 1.15
Effect of 2-deoxyglucose on cell wall formation in Saccharomyces cerevisiae and its relation to cell growth inhibition. J Bacteriol (1971) 1.13
Maximal exponential growth rate and yield of E. coli obtainable in a bench-scale fermentor. Biotechnol Bioeng (1974) 1.13
Lupus-like autoimmune disease induced by interferon therapy for myeloproliferative disorders. Clin Immunol Immunopathol (1992) 1.12
A single origin of phenylketonuria in Yemenite Jews. Nature (1990) 1.11
Detection of soluble HLA-G molecules in plasma and amniotic fluid. Tissue Antigens (1999) 1.11
T-Cell response to woodchuck hepatitis virus (WHV) antigens during acute self-limited WHV infection and convalescence and after viral challenge. J Virol (1998) 1.10
The oxidation of fatty acids by a particulate fraction from desert-locust (Schistocerca gregaria) thorax tissues. Biochem J (1960) 1.10
Impact of localized radiotherapy on blood immune cells counts and function in humans. Radiother Oncol (1999) 1.10
In vivo CTL induction with point-substituted ovalbumin peptides: immunogenicity correlates with peptide-induced MHC class I stability. Vaccine (1995) 1.10
Expansion of cytokine-producing CD4-CD8- T cells associated with abnormal Fas expression and hypereosinophilia. J Exp Med (1996) 1.08
Progressive liver calcifications in neonatal coxsackievirus infection. Pediatr Radiol (2000) 1.07
Soluble human leukocyte antigen--G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy. Cancer (2001) 1.06
Crystal structure of the murine NK cell-activating receptor NKG2D at 1.95 A. Nat Immunol (2001) 1.06
RP1, a new member of the adenomatous polyposis coli-binding EB1-like gene family, is differentially expressed in activated T cells. J Immunol (1997) 1.06
The predictive value of MDR1, CYP2C9, and CYP2C19 polymorphisms for phenytoin plasma levels. Pharmacogenomics J (2001) 1.05
Acquired von Willebrand's disease in the myeloproliferative syndrome. Blood (1984) 1.05
Joint report of the Second International Workshop on Canine Immunogenetics. Transplant Proc (1976) 1.05
Sibling vesicoureteral reflux in multiple gestation births. Pediatrics (2000) 1.04
The effect of a short message service maintenance treatment on body mass index and psychological well-being in overweight and obese children: a randomized controlled trial. Pediatr Obes (2012) 1.04
Non-radioactive determination of inosine 5'-monophosphate dehydro-genase (IMPDH) in peripheral mononuclear cells. Clin Biochem (2001) 1.03
Vesicoureteral reflux in asymptomatic siblings of patients with known reflux: radionuclide cystography. Pediatrics (1987) 1.03
Suppression of delayed-type hypersensitivity to PPD and PHA in elderly HTLV-I carriers. J Acquir Immune Defic Syndr (1990) 1.03
Site of mannan synthesis in yeast. An autoradiographic study. Arch Microbiol (1974) 1.02
The formation of guanosine diphosphate-2-deoxy-D-glucose in yeast. Biochim Biophys Acta (1968) 1.01
Inhibitory effect of 2-deoxy-d-glucose on the formation of the cell wall in yeast protoplasts. J Bacteriol (1969) 1.01
Surface markers and mitogen response of cells harvested from cutaneous infiltrates in mycosis fungoides and Sézary's syndrome. J Invest Dermatol (1978) 1.01
Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls. J Clin Invest (1998) 1.00
Polymers and nanoparticles: intelligent tools for intracellular targeting? Eur J Pharm Biopharm (2007) 1.00
Long-term followup of newborns with myelodysplasia and normal urodynamic findings: Is followup necessary? J Urol (2001) 1.00
The physician assistant: Shifting the Paradigm of European medical practice? HSR Proc Intensive Care Cardiovasc Anesth (2011) 1.00
Catecholamines increase lymphocyte beta 2-adrenergic receptors via a beta 2-adrenergic, spleen-dependent process. Am J Physiol (1990) 0.99
Suppression of tuberculin skin reaction in healthy HTLV-I carriers from Japan. Int J Cancer (1988) 0.99
Lysis of Saccharomyces cerevisiae with 2-deoxy-2-fluoro-D-glucose, an inhibitor of the cell wall glucan synthesis. J Bacteriol (1973) 0.99
Prevalence of latent tuberculosis infection in German radiologists. J Hosp Infect (2008) 0.99
Successful graft of HTLV-I-transformed human T-cells (MT-2) in severe combined immunodeficiency mice treated with anti-asialo GM-1 antibody. Jpn J Cancer Res (1992) 0.99
Vitamin B6 deficiency in uremia and its implications for the depression of immune responses. Kidney Int (1974) 0.98
Increase in cerivastatin systemic exposure after single and multiple dosing in cyclosporine-treated kidney transplant recipients. Clin Pharmacol Ther (1999) 0.98
Sorafenib as third- or fourth-line treatment of advanced gastrointestinal stromal tumour and pretreatment including both imatinib and sunitinib, and nilotinib: A retrospective analysis. Eur J Cancer (2012) 0.97
The G protein beta3 subunit 825T allele is a genetic marker for enhanced T cell response. FEBS Lett (2001) 0.97